Janus Kinase Inhibitor [EPC] class drugs

8 results

  • cibinqo - abrocitinib tablet, film coated

    (Abrocitinib)
    U.S. Pharmaceuticals
    CIBINQO treats moderate-to-severe atopic dermatitis in adults and pediatric patients 12 and older whose disease is not adequately controlled by other systemic therapies, including biologics, or when those therapies are inadvisable. Not recommended with other JAK inhibitors, biologic immunomodulators, or immunosuppressants.
    Medication Details
    Drug Interactions

  • jakafi - ruxolitinib tablet

    (Ruxolitinib)
    Incyte Corporation
    Jakafi treats intermediate or high-risk myelofibrosis and polycythemia vera (in adults intolerant of or unresponsive to hydroxyurea). Also indicated for steroid-refractory acute and chronic graft-versus-host disease in adults and pediatric patients 12 and older.
    Medication Details
    Drug Interactions

  • olumiant - baricitinib tablet, film coated

    (Baricitinib)
    Eli Lilly And Company
    Olumiant (baricitinib) treats adults with moderately-to-severely active rheumatoid arthritis after TNF blocker failure, hospitalized adults with COVID-19 requiring oxygen or mechanical ventilation, and adults with severe alopecia areata.
    Medication Details
    Drug Interactions

  • rinvoq - upadacitinib tablet, extended release

    (Upadacitinib)
    Abbvie Inc.
    Rinvoq is a JAK inhibitor for adults and some children with rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis, or giant cell arteritis - typically after other treatments have failed.
    Medication Details
    Drug Interactions